{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:46:03Z","timestamp":1790718363047,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jns.2023.120805","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T08:55:14Z","timestamp":1694508914000},"page":"120805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment"],"prefix":"10.1016","volume":"453","author":[{"given":"Giulia","family":"Giacomucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Crucitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Ingannato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Padiglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Galdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Emiliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Morinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Sorbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Nacmias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.120805_bb0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2023.120805_bb0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120805_bb0015","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120805_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120805_bb0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120805_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120805_bb0040","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120805_bb0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jns.2023.120805_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10072-018-3620-y","article-title":"Subjective cognitive decline: preclinical manifestation of Alzheimer\u2019s disease","volume":"40","author":"Lin","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2023.120805_bb0055","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/alz.12512","article-title":"Characteristics of subjective cognitive decline associated with amyloid positivity","volume":"18","author":"Janssen","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120805_bb0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1590\/1980-57642020dn14-030007","article-title":"Subjective cognitive decline as a predictor of future cognitive decline: a systematic review","volume":"14","author":"Parfenov","year":"2020","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.jns.2023.120805_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/acps.12336","article-title":"Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis","volume":"130","author":"Mitchell","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jns.2023.120805_bb0070","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/alz.12447","article-title":"Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer\u2019s disease","volume":"18","author":"Chatterjee","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120805_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","article-title":"Neurochemical diagnosis of Alzheimer\u2019s dementia by CSF Abeta42, Abeta42\/Abeta40 ratio and total tau","volume":"25","author":"Lewczuk","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2023.120805_bb0080","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jns.2023.120805_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study","volume":"11","author":"Clark","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0090","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","article-title":"Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: phase 3 study","volume":"11","author":"Sabri","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120805_bb0095","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2967\/jnumed.119.236224","article-title":"Tau PET imaging with 18F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study","volume":"61","author":"Mueller","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jns.2023.120805_bb0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2023.120805_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamaneurol.2018.2505","article-title":"Mechanisms of cell-to-cell transmission of pathological tau: a review","volume":"76","author":"Gibbons","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2023.120805_bb0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0120","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2023.120805_bb0125","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jns.2023.120805_bb0130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero Rodriguez","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2023.120805_bb0140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41398-021-01476-7","article-title":"Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer\u2019s disease","volume":"11","author":"Chen","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jns.2023.120805_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum","volume":"144","author":"Moscoso","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jns.2023.120805_bb0150","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1038\/s41598-017-08779-0","article-title":"Tau plasma levels in subjective cognitive decline: results from the DELCODE study","volume":"7","author":"M\u00fcller","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2023.120805_bb0155","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/cns.13962","article-title":"Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients","volume":"28","author":"Huang","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jns.2023.120805_bb0160","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120805_bb0165","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10072-012-1130-x","article-title":"Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population","volume":"34","author":"Monaco","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2023.120805_bb0170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000117297","article-title":"The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the mental deterioration battery","volume":"36","author":"Carlesimo","year":"1996","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0175","series-title":"Prove di memoria verbale di impiego clinico per la diagnosi di amnesia","author":"De Renzi","year":"1977"},{"key":"10.1016\/j.jns.2023.120805_bb0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s100720200003","article-title":"Rey-Osterrieth complex figure: normative values in an Italian population sample","volume":"22","author":"Caffarra","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2023.120805_bb0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01997792","article-title":"Trail making test: normative values from 287 normal adult controls","volume":"17","author":"Giovagnoli","year":"1996","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2023.120805_bb0190","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1017\/S0033291700038460","article-title":"A cancellation test: its reliability in assessing attentional deficits in Alzheimer\u2019s disease","volume":"22","author":"Della Sala","year":"1992","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jns.2023.120805_bb0195","first-page":"477","article-title":"Tre test clinici di ricerca e produzione lessicale. Taratura su sogetti normali.\/Three clinical tests to research and rate the lexical performance of normal subjects","author":"Novelli","year":"1970","journal-title":"Arch. Psicol. Neurol. Psichiatr."},{"key":"10.1016\/j.jns.2023.120805_bb0200","series-title":"Standardizzazione e taratura italiana di test neuropsicologici: gruppo italiano per lo studio neuropsicologico dell\u2019invecchiamento","author":"Spinnler","year":"1987"},{"key":"10.1016\/j.jns.2023.120805_bb0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s100720200003","article-title":"Rey-Osterrieth complex figure: normative values in an Italian population sample","volume":"22","author":"Caffarra","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2023.120805_bb0210","first-page":"111","article-title":"Una versione abbreviata del test di Stroop: Dati normativi nella popolazione Italiana","volume":"12","author":"Caffarra","year":"2002","journal-title":"Riv. Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S1041610292000991","article-title":"Assessment of memory complaint in age-associated memory impairment: the MAC-Q","volume":"4","author":"Crook","year":"1992","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.jns.2023.120805_bb0220","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/acn3.50873","article-title":"Agreement of amyloid PET and CSF biomarkers for Alzheimer\u2019s disease on Lumipulse","volume":"6","author":"Alcolea","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0225","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","article-title":"SNMMI procedure standard\/EANM practice guideline for amyloid PET imaging of the brain 1.0","volume":"57","author":"Minoshima","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jns.2023.120805_bb0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0304-3940(94)90054-X","article-title":"ApoE allele frequencies in Italian sporadic and familial Alzheimer\u2019s disease","volume":"177","author":"Sorbi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2023.120805_bb0235","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jns.2023.120805_bb0240","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41398-021-01709-9","article-title":"Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer\u2019s amyloid, tau and FDG PET status","volume":"11","author":"Shen","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jns.2023.120805_bb0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41380-020-00923-z","article-title":"Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer\u2019s disease neuroimaging Initiative","volume":"26","author":"Karikari","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jns.2023.120805_bb0250","article-title":"Objective subtle cognitive decline and plasma phosphorylated tau181: early markers of Alzheimer\u2019s disease-related declines","volume":"13","author":"Thomas","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.jns.2023.120805_bb0255","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0260","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain \u03b2-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120805_bb0265","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment","author":"Giacomucci","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jns.2023.120805_bb0275","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","article-title":"Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of Alzheimer\u2019s disease (INSIGHT-preAD): a longitudinal observational study","volume":"17","author":"Dubois","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120805_bb0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum","volume":"144","author":"Moscoso","year":"2021","journal-title":"Brain"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:03:04Z","timestamp":1758384184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23002666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":56,"alternative-id":["S0022510X23002666"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120805","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120805"}}